Italy lifts ban on Novartis flu vaccines

Italian health authorities on Friday lifted a ban on the sale of flu vaccines made by Swiss pharmaceutical giant Novartis, saying that tests had shown they were not a health risk.

"The decision was made possible due to in-depth checks which were carried out as a precaution to protect public health," Italy's public agency for pharmaceuticals AIFA said in a statement.

Italy's health ministry last month ordered a ban on Aggripal, Fluad and Influpozzi after white particles were seen in syringes carrying the vaccines.

Austria, Canada, Germany and Switzerland subsequently also ordered temporary bans although some have since been lifted.

Novartis has said it is confident on the "safety and efficacy" of its vaccines.

add to favorites email to friend print save as pdf

Related Stories

Germany orders recall of some Novartis flu shots

Oct 25, 2012

(AP)—German authorities ordered a recall Thursday of some batches of Novartis flu vaccine as a precautionary measure after the company reported the appearance of small particles in the manufacturing process.

EU drug agency: License 2 swine flu vaccines

Sep 25, 2009

(AP) -- The European Union's drug regulator recommended Friday that two swine flu vaccines be licensed in the 27-nation bloc to ensure their availability before the start of the normal flu season.

Recommended for you

Study recalculates costs of combination vaccines

18 hours ago

One of the most popular vaccine brands for children may not be the most cost-effective choice. And doctors may be overlooking some cost factors when choosing vaccines, driving the market toward what is actually a more expensive ...

Drug watchdog urges vigilance in cancer drug theft

22 hours ago

Europe's medicine watchdog urged doctors Thursday to be vigilant in administering the cancer drug Herceptin, vials of which had been stolen in Italy and tampered with before being sold back into the supply chain.

Pyridoxine-doxylamine drug safety data lacking

Apr 16, 2014

(Medical Xpress)—The most commonly prescribed drug for pregnant women suffering from morning sickness in their first trimester does not prevent birth defects even though drug safety data says it does, according to research ...

User comments